NEWS

ADVERTISEMENT
3rd party Ad. Not an offer or recommendation by techgolly.com.

Neuroenhancement Drugs are the Future of Cognitive Enhancement

Key Points: Significant progress in neuroenhancement drugs is poised to enhance cognitive functions like memory, creativity, and concentration. Promising drug shows exceptional memory retention and executive function results with minimal side effects. Issues of fairness, accessibility, and long-term effects prompt the need...

Latest NEWS

OpenAI Buys Astral to Boost AI Coding Assistant

Key Points: OpenAI is acquiring Astral to enhance its AI coding assistant, Codex. Astral's team will join OpenAI, bringing their expertise in developer tools. Codex currently boasts over 2 million weekly active users, tripling its growth this year. This acquisition is part of OpenAI's broader strategy of buying companies to gain a competitive edge. OpenAI announced Thursday that it's buying Astral, a small company known...

Xiaomi Pledges $8.7 Billion for AI in Next Three Years

Key Points: Xiaomi will invest at least 60 billion yuan ($8.7 billion) in AI. The investment will span over the next three years. Xiaomi announced its latest AI model, MiMo-V2-Pro. The company aims to enhance AI capabilities across its products. Xiaomi (1810.HK) is making a massive bet on artificial intelligence, with CEO Lei Jun announcing a commitment of at least 60 billion yuan ($8.70 billion)...

Alibaba’s Earnings Dip Amid Heavy AI Investments

Key Points: Alibaba's net income dropped 66% year-over-year. Revenue missed analyst expectations, reaching 284.8 billion Chinese yuan. Heavy investments in AI, quick commerce, and user experience impacted operational income. Cloud business revenue grew 36%, with AI-related products showing triple-digit growth. Alibaba, the Chinese tech giant, saw its net income tumble by 66% year-over-year, missing analyst revenue expectations for the fiscal quarter ending December 31, 2025....